Company facts
- Industry
- Services-Medical Laboratories
- Headquarters
- Brisbane, California
- Most recent report
- 10-Q, filed Jul 30, 2026
- Incorporated
- Delaware
- Filings on record
- 1,003+ filings
- On EDGAR
- CIK 1217234
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 37
News 8 of 118
Prospectuses and Registrations 8 of 31
- S-8 Registration statement for an employee plan Jul 30, 2026
- S-3ASR Automatic shelf registration Apr 28, 2026
- S-8 Registration statement for an employee plan Nov 4, 2025
- S-8 Registration statement for an employee plan Sep 13, 2024
- S-8 Registration statement for an employee plan Jun 21, 2024
- POS AM Post-effective amendment to a registration May 23, 2024
- POS AM Post-effective amendment to a registration May 9, 2024
- S-8 Registration statement for an employee plan Apr 25, 2024
Proxies 8 of 23
- DEFA14A Extra proxy material Jun 5, 2026
- DEFA14A Extra proxy material Apr 27, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2026
- DEFA14A Extra proxy material Apr 28, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2025
- DEFA14A Extra proxy material Apr 29, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2024
- DEFA14A Extra proxy material May 1, 2023
Ownership 8 of 776
- 144 Notice of a proposed sale of restricted stock Aug 17, 2026
- 144 Notice of a proposed sale of restricted stock Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- 144 Notice of a proposed sale of restricted stock Aug 13, 2026
- 144 Notice of a proposed sale of restricted stock Aug 12, 2026
- 144 Notice of a proposed sale of restricted stock Aug 11, 2026
- 144 Notice of a proposed sale of restricted stock Aug 10, 2026
- 144 Notice of a proposed sale of restricted stock Aug 10, 2026
Other 8 of 18
- ARS Annual report sent to shareholders Apr 27, 2026
- ARS Annual report sent to shareholders Apr 28, 2025
- EFFECT Notice that a registration became effective May 23, 2024
- ARS Annual report sent to shareholders Apr 30, 2024
- POSASR Feb 28, 2024
- ARS Annual report sent to shareholders Apr 28, 2023
- CT ORDER Dec 22, 2021
- UPLOAD Comment letter from SEC staff Sep 1, 2020
Everything here comes from CareDx, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.